1. Home
  2. INSP vs TMDX Comparison

INSP vs TMDX Comparison

Compare INSP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$138.09

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
TMDX
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.9B
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
INSP
TMDX
Price
$138.09
$136.66
Analyst Decision
Buy
Buy
Analyst Count
15
10
Target Price
$127.07
$133.00
AVG Volume (30 Days)
1.5M
835.5K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
34.77
170.70
EPS
1.48
2.54
Revenue
$882,622,000.00
$566,354,000.00
Revenue This Year
$14.97
$38.84
Revenue Next Year
$11.81
$20.43
P/E Ratio
$92.68
$53.83
Revenue Growth
16.81
41.20
52 Week Low
$70.77
$55.00
52 Week High
$216.01
$156.00

Technical Indicators

Market Signals
Indicator
INSP
TMDX
Relative Strength Index (RSI) 76.95 54.31
Support Level $132.39 $133.50
Resistance Level $142.56 $156.00
Average True Range (ATR) 7.26 8.50
MACD 3.75 0.41
Stochastic Oscillator 90.18 55.98

Price Performance

Historical Comparison
INSP
TMDX

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: